Sign in

Brittany Harvey

@brittanyeharvey.bsky.social
853 followers 188 following 30 posts

Clinical Practice Guidelines @ ASCO. Washington, DC. Opinions mine. She/Her.

PostsRepliesMedia
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 19/12/2025
Our draft guideline recommendations for Systemic Treatment of Patients with Ovarian Cancer Experiencing Recurrence are now available for open comment. Submit feedback to us by January 7: brnw.ch/21wYuR2
021
Brittany Harvey @brittanyeharvey.bsky.social · 11/12/2025
New evidence-based guideline from @ascocancer.bsky.social on the management of cancer during pregnancy. I had a great conversation with Dr. Alison Loren (@pennmedicine.bsky.social) and Dr. Ann Partridge (@danafarber.bsky.social) on the ASCO Guidelines Podcast guideline.libsyn.com/management-o...
guideline.libsyn.com
ASCO Guidelines: Management of Cancer During Pregnancy Guideline
Dr. Alison Loren and Dr. Ann Partridge share the latest guideline from ASCO on the management of cancer during pregnancy. They highlight the importance of this multidisciplinary, evidence-based guidel...
120
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 21/05/2025
🚨New from ASCO: The ASCO Guidelines Assistant, a new generative AI tool developed in collaboration with Google Cloud, more quickly connects ASCO members with timely and trustworthy information. #ASCO25 Learn more: brnw.ch/21wSP18
073
Reposted by Brittany Harvey
ACOG @acog.org · 27/05/2025
ACOG is deeply disappointed by HHS’s move to drop COVID-19 vaccine recommendations in pregnancy. The science is clear: COVID-19 remains dangerous in pregnancy and vaccination protects both patients and newborns. The vaccine is safe and protects families. Read our full statement: buff.ly/OGue7sO
13521334
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 02/05/2025
Check out our new rapid recommendation update on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults. Read full article: brnw.ch/21wSn7M
064
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 01/05/2025
Our draft guideline recommendations, White Blood Cell Growth Factors, are now available for open comment. Contribute to the advancement of clinical guidelines and enhance your professional impact. Submit feedback to us by May 15: brnw.ch/21wSljI
042
Brittany Harvey @brittanyeharvey.bsky.social · 30/04/2025
Rapid recommendation update from @ascocancer.bsky.social & @neuroonc.bsky.social on therapy for diffuse astrocytic & oligodendroglial tumors in adults #ASCOguidelines #oncsky #medsky ascopubs.org/doi/full/10....
Visual Abstract for ASCO-SNO Guideline
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults
Rapid Guideline Update
Oligodendroglioma, IDH-mutant, 1p19q co-deleted, CNS WHO grade 2
Options Include:
- RT + PCV
- When toxicity is a concern, RT + temozolimide
- For some people with favorable prognostic factors or concerns about toxicity, deferred RT + chemotherapy until radiographic or symptomatic progression
- After 1+ surgeries, when RT + chemotherapy has been or can be deferred, vorasidenib may be offered

Astrocytoma, IDH-mutant, 1p19q non-codeleted, CNS WHO grade 2
Options include:
- RT + adjuvant chemotherapy (temozolimide or PCV)
- For some people with favorable prognostic factors or concerns about short- and long-term toxicity, deferred RT + chemotherapy until radiographic or symptomatic progression
- After 1+ surgeries, when RT + chemotherapy has been or can be deferred, vorasidenib may be offered

Mohile et al J Clin Oncol 2025
asco.org/neurooncology-guidelines
120
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 22/04/2025
Check out our new clinical insights on Fertility Preservation in People With Cancer. This is a companion piece to the updated guideline, published online in the JCO Oncology Practice. Read more. brnw.ch/21wS8TZ
brnw.ch
ASCO Publications
062
Reposted by Brittany Harvey
Winship Cancer Institute of Emory University @winshipcancer.emory.edu · 16/04/2025
An expert panel from the American Society of Clinical Oncology, co-chaired by Winship's Mylin Torres, MD, has published updated recommendations for sentinel lymph node biopsy in early-stage breast cancer patients post-surgery. ➡️ brnw.ch/21wS0Eb
021
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 14/04/2025
Key update in cancer pain management! Check out our latest “Science in Seconds” with Drs. Mellar Davis & Akhila Reddy as they discuss our new guideline “Opioid Conversion in Adults with Cancer.”
064
Brittany Harvey @brittanyeharvey.bsky.social · 11/04/2025
Our latest guideline update on sentinel lymph node biopsy in patients with early-stage breast cancer treated with initial surgery @ascocancer.bsky.social #ASCOguidelines #MedSky #OncSky
ASCO Guidelines Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Guideline Update
This guideline updates recommendations on the use of SLNB in patients with early-stage breast cancer treated with initial surgery, and includes the following topics:
When SLNB can be omitted
When ALND is indicated
Radiation and systemic treatment decisions after SLNB omission
Role of SLNB in special circumstances
Park et al J Clin Oncol 2025
asco.org/breast-cancer-guidelines
151
Reposted by Brittany Harvey
Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 08/04/2025
Want to join us in our efforts? Visit asco.org/actnetwork to contact your Members of Congress about the issues that matter most to you! Advocates are also on the Hill to fix #PriorAuth and protect #CancerResearch funding. #ASCOAdvocacy @ascocancer.bsky.social
asco.org
Engage in ASCO's Advocacy Efforts
Write a letter to your lawmaker today!
094
Reposted by Brittany Harvey
Estelamari Rodríguez @latinamd.bsky.social · 22/03/2025
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8 ➡️ fertility preservation options for men/women/children ➡️ established and emerging methods discussed
034
Brittany Harvey @brittanyeharvey.bsky.social · 28/03/2025
Protocol for future ASCO guideline on patient-reported outcomes available for comment through Wednesday, April 9 @ascocancer.bsky.social #ASCOguidelines #OncSky #MedSky app.smartsheet.com/b/form/ecf22...
app.smartsheet.com
Smartsheet Forms
031
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 26/03/2025
What health policies do you think we should develop? Tell us using our topic submission form. Submit here ➡️ brnw.ch/21wRxhq Tell us about: 🔵 the issue 🔵 how the policy aligns with ASCO’s goals 🔵 suggestions for potential policy writers
074
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 19/03/2025
Attention to reproductive care is essential before cancer therapy begins.” Our latest ‘Science in Seconds’ features Dr. Alison Loren and Dr. Hui-chun Irene Su discussing our updated fertility preservation guideline. Learn more about this guideline: brnw.ch/21wRrAm
0118
Brittany Harvey @brittanyeharvey.bsky.social · 19/03/2025
New guideline update on fertility preservation in people with cancer from @ascocancer.bsky.social Topics include established, emerging, & investigational fertility preservation methods for adults & children and importance of discussing infertility risks with all patients ascopubs.org/doi/10.1200/...
ASCO Guidelines Fertility Preservation in People with Cancer
Guideline update including recommendations on:
Discussing Risks of Infertility
Role of Clinicians
Fertility Preservation in Males
Established or Emerging Methods Include:
- Sperm cryopreservation
- Testicular sperm extraction
Fertility Preservation in Females
Established or Emerging Methods Include:
- Embryo or oocyte cryopreservation
- Ovarian tissue cryopreservation
- Ovarian transposition
- Conservative gynecologic surgery
- In vitro maturation
Fertility Preservation in Children
Established or Emerging Methods Include:
- For those who have begun puberty: semen, oocyte, or ovarian tissue cryopreservation
- For pre-pubertal females: ovarian tissue cryopreservation
Su et al J Clin Oncol 2025
asco.org/survivorship-guidelines
130
Reposted by Brittany Harvey
Andrew Lautz @andrewlautz.bsky.social · 15/03/2025
Me convincing myself my 401(k) balance isn't down if I don't check it:
021
Brittany Harvey @brittanyeharvey.bsky.social · 05/03/2025
Protocol for the @ascocancer.bsky.social guideline update on management of immune-related adverse effects available for open comment through March 19 #ASCOguidelines #irAEs #MedSky #OncSky #SuppOnc app.smartsheet.com/b/form/e3689...
app.smartsheet.com
Smartsheet Forms
020
Reposted by Brittany Harvey
Janet Freeman-Daily @jfreemandaily.bsky.social · 02/03/2025
Updated @ascocancer.bsky.social living guidelines for NSCLC are out! Participating on the Expert Panel not only gives me hope to see so many new treatments, it also reminds me how challenging it must be for clinicians to keep up. ascopubs.org/doi/10.1200/... ascopubs.org/doi/10.1200/...
ascopubs.org
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedul...
0162
Reposted by Brittany Harvey
Estelamari Rodríguez @latinamd.bsky.social · 02/03/2025
🔥🔥Off the press Updated @ASCO Living Guidelines on Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations, Version 2024.3 ▶️ Discussion of 2nd line options ▶️ Update on T-Dxd for HER2 IHC3+ lungcancer ▶️ No consensus on use of TTF, Dato-DXd 👉🏽 ascopubs.org/doi/10.1200/...
011
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 27/02/2025
We’ve issued a guideline update on therapy for stage IV #NSCLC without driver alterations. #lungcancer #LCSM Read more: brnw.ch/21wR0fb
012
Reposted by Brittany Harvey
American Society of Clinical Oncology @ascocancer.bsky.social · 27/02/2025
Just issued: new living guideline update on therapy for stage IV #NSCLC with driver alterations. Read more: brnw.ch/21wR0fn #LungCancer #LCSM
055
Brittany Harvey @brittanyeharvey.bsky.social · 27/02/2025
Updates just released for two companion living @ascocancer.bsky.social guidelines on stage IV NSCLC Updated recommendations for stage IV NSCLC without driver alterations include a new second-line option for patients with good PS & HER2 overexpression #ASCOguidelines ascopubs.org/doi/10.1200/...
Visual abstract describing updated recommendations in the 2024.3 version of the therapy for stage IV NSCLC without driver alterations guideline
110
Brittany Harvey @brittanyeharvey.bsky.social · 11/02/2025
New evidence-based @ascocancer.bsky.social guideline out on TORS in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma #ASCOguidelines ascopubs.org/doi/full/10....
ASCO Guidelines
Transoral Robotic Surgery in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma
Guideline update including recommendations on:
Evaluation & Workup of Patients with OPC for TORS
Goal of TORS
Patient Selection
Adjuvant Therapy
Role of TORS in HPV-negative OPC
Use of TORS in Salvage or Recurrent Setting
Holsinger et al J Clin Oncol 2025
asco.org/head-neck-cancer-guidelines
110
Reposted by Brittany Harvey
Dee Sparacio @womenofteal.bsky.social · 24/01/2025
Proud to have been part of this updated guideline Check out the updated ASCO guideline: Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer society.asco.org/neoadjuvant-... #gyncsm Recommendations include: 1/ 3
society.asco.org
Gynecologic Cancer
Gynecologic Cancer
1122
Brittany Harvey @brittanyeharvey.bsky.social · 23/01/2025
New update to the neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer from @ascocancer.bsky.social covering many evidence-based recommendations on the use of NACT across ten clinical questions #ASCOguidelines #medsky #oncsky ascopubs.org/doi/full/10....
ASCO Guidelines Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
Guideline update including recommendations on:
Initial Assessment
Primary Cytoreductive Surgery
Neoadjuvant Chemotherapy
Confirmation of Diagnosis
Preferred Chemotherapy Regimens
Timing of Interval Cytoreductive Surgery
Role of Hyperthermic Intraperitoneal Chemotherapy
Recommended Number of Chemotherapy Cycles
Maintenance Therapy
Options for Patients with Progressive Disease on Neoadjuvant Chemotherapy
Gaillard et al J Clin Oncol 2025
asco.org/gynecologic-cancer-guidelines
130
Reposted by Brittany Harvey
Angela Cochran @acochran12733.bsky.social · 23/01/2025
Just published! New ASCO Guideline Update: Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update ascopubs.org/doi/10.1200/... #JCO #JCOJournals #Guidelines
ascopubs.org
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...
173
Brittany Harvey @brittanyeharvey.bsky.social · 09/01/2025
Latest guideline from @ascocancer.bsky.social on germline & somatic genomic testing for metastatic prostate cancer published today #ASCOguidelines #medsky #oncsky ascopubs.org/doi/full/10....
ASCO Guidelines Germline & Somatic Genomic Testing for Metastatic Prostate Cancer
Includes algorithm on flow of genomic/somatic testing and genetic testing for all patients with metastatic prostate cancer.
Yu et al J Clin Oncol 2025
asco.org/genitourinary-cancer-guidelines
120
Brittany Harvey @brittanyeharvey.bsky.social · 08/01/2025
New Treatment of Pleural Mesothelioma Guideline Update just released from @ascocancer.bsky.social! Includes recommendations on diagnosis & staging, surgery, immunotherapy, chemotherapy, radiation therapy, pathology & germline testing #ASCOguidelines #medsky #oncsky ascopubs.org/doi/full/10....
ASCO Guidelines: Treatment of Pleural Mesothelioma
Guideline update including recommendations on: Diagnosis and Staging, Surgery, Immunotherapy, Chemotherapy, Radiation Therapy, Pathology, Germline Testing
Kindler et al J Clin Oncol 2025
asco.org/thoracic-cancer-guidelines
140
Brittany Harvey @brittanyeharvey.bsky.social · 17/12/2024
Dr. @vanmorrismd.bsky.social discussed the new evidence-based guideline on systemic therapy for localized anal squamous cell carcinoma with me on the #ASCOguidelines podcast - highlighting key recs, considerations for special populations & future research areas podcasts.apple.com/us/podcast/s...
podcasts.apple.com
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline
Podcast Episode · ASCO Guidelines · 12/16/2024 · 16m
010
Brittany Harvey @brittanyeharvey.bsky.social · 17/12/2024
New guideline just out from ASCO on systemic therapy for stage I-III anal squamous cell carcinoma #ASCOguidelines #MedSky #OncSky ascopubs.org/doi/full/10....
ascopubs.org
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...
041
Reposted by Brittany Harvey
Dr. Beverly Moy @beverlymoy.bsky.social · 16/12/2024
@ascocancer.bsky.social #ASCOGuidelines out today "Systemic Therapy for Stage I-III Anal Carcinoma" with guidance about radiosensitization, dose/scheduling options, and much more. @vanmorrismd.bsky.social @cathyengmd.bsky.social Read at society.asco.org/practice-pat...
society.asco.org
Gastrointestinal Cancer
Gastrointestinal Cancer
052
Brittany Harvey @brittanyeharvey.bsky.social · 03/12/2024
One org I’m supporting on #GivingTuesday is Camp Kesem GW, a free summer camp & year-round support network for kids affected by a parent’s cancer. As a former volunteer & current advisory board member, I see the impact of their programs & encourage you to donate too! donate.kesem.org/fundraiser/5...
donate.kesem.org
Kesem 2025
{{MetaTags.description}}
010
Brittany Harvey @brittanyeharvey.bsky.social · 25/11/2024
The protocol for the future ASCO guideline on the systemic treatment of thyroid cancer is open for comment through Dec 2: society.asco.org/practice-pat... #medsky #oncsky
society.asco.org
Open Comment of Guidelines
Open comment allows for key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication.
030
Reposted by Brittany Harvey
Julie Gralow @jrgralow.bsky.social · 23/11/2024
ASCO annual meeting 2025 abstract submitter open - closes Jan 28th. To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)! Apply for a waiver when you submit an abstract conferences.asco.org/am/abstract-...
conferences.asco.org
ASCO Meetings
23722
Reposted by Brittany Harvey
Angela Cochran @acochran12733.bsky.social · 21/11/2024
Just published in #JCO Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update #SCLC, #oncsky #medsky #Guidelines ascopubs.org/doi/10.1200/...
ascopubs.org
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update | Journal of Clinical Oncology
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an e...
1102
Reposted by Brittany Harvey
Jill Feldman @jillfeldman4.bsky.social · 21/11/2024
Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional. This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/... #LCSM
ascopubs.org
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update | Journal of Clinical Oncology
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an e...
2398
Brittany Harvey @brittanyeharvey.bsky.social · 20/11/2024
New rapid recommendation update on systemic therapy for small-cell lung cancer from ASCO just published: ascopubs.org/doi/full/10.... #ASCOguidelines #MedSky #OncSky #LCSM
Visual abstract for Systemic Therapy for SCLC Rapid Guideline Update:
2.4. Patients with LS-SCLC who have completed concurrent chemoradiotherapy and do not have disease progression should be offered consolidation immunotherapy (durvalumab) for up to 2 years if there are no contraindications to immunotherapy. (Evidence quality: Moderate; Strength of recommendation: Strong)

5.3.1. Patients with LS-SCLC and ECOG PS 3-4 due to SCLC who have been treated with concurrent or sequential chemotherapy and radiotherapy may be offered consolidation immunotherapy (durvalumab) for up to 2 years if there are no contraindications to immunotherapy and there is improvement in PS. (Evidence quality: Low; Strength of recommendation: Conditional)

4.1. In patients with relapsed SCLC with a chemotherapy-free interval of less than 90 days, single-agent systemic therapy may be offered. Preferred agents are topotecan, lurbinectedin or tarlatamab. (Evidence quality: Moderate; Strength of recommendation: Strong)

4.2. In patients with relapsed SCLC with a chemotherapy-free interval of at least 90 days, re-challenge with a platinum-based regimen or single-agent chemotherapy (preferred agents are topotecan, lurbinectedin or tarlatamab) may be offered. (Evidence quality: Moderate; Strength of recommendation: Strong)

Kalemkerian et al J Clin Oncol 2024
asco.org/thoracic-cancer-guidelines
2167
Reposted by Brittany Harvey
Stephen Liu @stephenvliu.bsky.social · 19/11/2024
ASCO has released an updated Rapid Recommendation for stage III NSCLC in JCO Oncology Practice. Update now includes targeted therapy: consolidation osimertinib after chemoradiation for #EGFR NSCLC, adjuvant osimertinib or alectinib for resected EGFR or ALK NSCLC. #LCSM ascopubs.org/doi/10.1200/...
ascopubs.org
Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights | JCO Oncology Practice
03515
Reposted by Brittany Harvey
Jill Feldman @jillfeldman4.bsky.social · 13/11/2024
📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/.... This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance. #LCSM #LCAM
03210
Brittany Harvey @brittanyeharvey.bsky.social · 12/11/2024
Latest update to the ASCO stage IV NSCLC living guidelines published today! This update focuses on first- and second-line options for patients with an EGFR exon 19 deletion or exon 21 L858R substitution #ASCOguidelines #MedSky #OncSky #LCSM ascopubs.org/doi/full/10....
Visual Abstract for the Therapy for Stage IV NSCLC with Driving Alterations Living Guideline.
Living Guideline Updated Recommendations
EGFR Exon 19 Deletion, Exon 21 L858R Substitution 
First-Line Treatment Options Update.
1.1. Clinicians should offer osimertinib.
1.1.1. Clinicians may offer osimertinib with platinum doublet chemotherapy or amivantamab plus lazertinib
Qualifying Statement: Although Recommendation 1.1 addresses many patients in the target population, the guideline manuscript presents additional options that may be reasonable, based on the evidence reviewed. In addition, use of osimertinib in patients previously treated with adjuvant tyrosine kinase inhibitors is not reflected in this guideline.
Second-Line & Subsequent Treatment Options Update.
2.2. For patients who have progressive disease on osimertinib or other EGFR TKIs without emergent T790M or other targetable alterations, clinicians may offer platinum-based chemotherapy with or without amivantamab
Qualifying Statement: Patients that do not pursue amivantamab plus chemotherapy may also consider chemotherapy plus bevacizumab if they have adenocarcinoma and bevacizumab is deemed safe.
2.2.2. For patients who have progressive disease on EGFR TKI, anti-PD-(L)1 agents with or without platinum chemotherapy are not recommended
190